Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 Hospitals期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Use of Multimodality Neoadjuvant Therapy for Esophageal Cancer in the United States: Assessment of 987 Hospitals

Authors:	Ryan P Merkow Karl Y Bilimoria Martin D McCarter Warren B Chow Clifford Y Ko David J Bentrem

Institution:	(1) Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA;(2) Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA;(3) Department of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA;(4) Department of Surgery, University of California, Los Angeles and VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA;(5) Department of Surgery, Jesse Brown VA Medical Center, Chicago, IL, USA;

Abstract:	Background Consensus guidelines recommend neoadjuvant therapy in locally advanced esophageal cancer; however, whether this recommendation has been widely adopted is unknown. Therefore, we evaluated the utilization of neoadjuvant therapy in esophageal cancer and its association with outcomes in the United States.

Keywords:
本文献已被 SpringerLink 等数据库收录！